Vasorelaxant effects of 3-methoxycatechol are not via direct activation of voltage-gated potassium channels

Rían W. Manville; Samuel N. Baldwin; Olivia H. Schaub; Thomas A. Jepps; Geoffrey W. Abbott

doi:10.1016/j.vph.2025.107471

Vasorelaxant effects of 3-methoxycatechol are not via direct activation of voltage-gated potassium channels

Rían W. Manville, Samuel N. Baldwin, Olivia H. Schaub, Thomas A. Jepps, Geoffrey W. Abbott^*

^*Corresponding author for this work

Physiology of circulation, kidney and lung

Research output: Contribution to journal › Letter › peer-review

Original language	English
Article number	107471
Journal	Vascular Pharmacology
Volume	159
Number of pages	4
ISSN	1537-1891
DOIs	https://doi.org/10.1016/j.vph.2025.107471
Publication status	Published - 2025

Keywords

3-methoxycatechol
CGRP receptor
Kv channels
Kv7.4
Kv7.5
Vasorelaxant

Access to Document

10.1016/j.vph.2025.107471

Cite this

@article{193a0afcd1b3413cb4216679f60e08e2,

title = "Vasorelaxant effects of 3-methoxycatechol are not via direct activation of voltage-gated potassium channels",

keywords = "3-methoxycatechol, CGRP receptor, Kv channels, Kv7.4, Kv7.5, Vasorelaxant",

author = "Manville, {R{\'i}an W.} and Baldwin, {Samuel N.} and Schaub, {Olivia H.} and Jepps, {Thomas A.} and Abbott, {Geoffrey W.}",

note = "Funding Information: This study was supported by the National Institute of General Medical Sciences , National Institutes of Health ( GM130377 to GWA), the Lundbeck Foundation ( R323-2018-3674 to TAJ) and Marie Sk\u0142odowska-Curie Actions Postdoctoral Fellowship ( 101108100 to SNB).",

year = "2025",

doi = "10.1016/j.vph.2025.107471",

language = "English",

volume = "159",

journal = "Vascular Pharmacology",

issn = "1537-1891",

publisher = "Elsevier",

}

TY - JOUR

T1 - Vasorelaxant effects of 3-methoxycatechol are not via direct activation of voltage-gated potassium channels

AU - Manville, Rían W.

AU - Baldwin, Samuel N.

AU - Schaub, Olivia H.

AU - Jepps, Thomas A.

AU - Abbott, Geoffrey W.

N1 - Funding Information: This study was supported by the National Institute of General Medical Sciences , National Institutes of Health ( GM130377 to GWA), the Lundbeck Foundation ( R323-2018-3674 to TAJ) and Marie Sk\u0142odowska-Curie Actions Postdoctoral Fellowship ( 101108100 to SNB).

PY - 2025

Y1 - 2025

KW - 3-methoxycatechol

KW - CGRP receptor

KW - Kv channels

KW - Kv7.4

KW - Kv7.5

KW - Vasorelaxant

U2 - 10.1016/j.vph.2025.107471

DO - 10.1016/j.vph.2025.107471

M3 - Letter

C2 - 39933640

AN - SCOPUS:85217920186

SN - 1537-1891

VL - 159

JO - Vascular Pharmacology

JF - Vascular Pharmacology

M1 - 107471

ER -